GB9307948D0 - Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease - Google Patents

Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease

Info

Publication number
GB9307948D0
GB9307948D0 GB939307948A GB9307948A GB9307948D0 GB 9307948 D0 GB9307948 D0 GB 9307948D0 GB 939307948 A GB939307948 A GB 939307948A GB 9307948 A GB9307948 A GB 9307948A GB 9307948 D0 GB9307948 D0 GB 9307948D0
Authority
GB
United Kingdom
Prior art keywords
lentivirus
treatment
biologically active
derivatives useful
induced disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939307948A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL, Carlo Erba SpA filed Critical Farmitalia Carlo Erba SRL
Priority to GB939307948A priority Critical patent/GB9307948D0/en
Publication of GB9307948D0 publication Critical patent/GB9307948D0/en
Priority to CA002137148A priority patent/CA2137148A1/en
Priority to UA94129236A priority patent/UA42693C2/en
Priority to RU94046312A priority patent/RU2142798C1/en
Priority to PL94306798A priority patent/PL306798A1/en
Priority to CZ95107A priority patent/CZ282988B6/en
Priority to JP6522676A priority patent/JPH07508044A/en
Priority to HU9500120A priority patent/HU216834B/en
Priority to AU65371/94A priority patent/AU670194B2/en
Priority to EP94913075A priority patent/EP0646004A1/en
Priority to PCT/EP1994/000984 priority patent/WO1994023718A1/en
Priority to IL10923594A priority patent/IL109235A/en
Priority to TW083103216A priority patent/TW308593B/zh
Priority to NO944809A priority patent/NO307126B1/en
Priority to KR1019940704567A priority patent/KR950701812A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB939307948A 1993-04-16 1993-04-16 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease Pending GB9307948D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GB939307948A GB9307948D0 (en) 1993-04-16 1993-04-16 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
PCT/EP1994/000984 WO1994023718A1 (en) 1993-04-16 1994-03-29 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
JP6522676A JPH07508044A (en) 1993-04-16 1994-03-29 Biologically active ureido derivatives effective in the treatment of diseases caused by lentiviruses
AU65371/94A AU670194B2 (en) 1993-04-16 1994-03-29 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
RU94046312A RU2142798C1 (en) 1993-04-16 1994-03-29 Agent based on biologically active ureido-derivatives for treatment of patients with infections caused by lentivirus
PL94306798A PL306798A1 (en) 1993-04-16 1994-03-29 Biologically active ureide derivatives useful in treating disease being breed by lentivirus
CZ95107A CZ282988B6 (en) 1993-04-16 1994-03-29 Use of biologically active ureido derivatives for treating diseases induced by a lentivirus
CA002137148A CA2137148A1 (en) 1993-04-16 1994-03-29 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
HU9500120A HU216834B (en) 1993-04-16 1994-03-29 Use of pyrrolyl- ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions
UA94129236A UA42693C2 (en) 1993-04-16 1994-03-29 The medicine for treating the infection by lentivirus, the preparation for human treatment which is infected by lentivirus.
EP94913075A EP0646004A1 (en) 1993-04-16 1994-03-29 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
IL10923594A IL109235A (en) 1993-04-16 1994-04-06 Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus induced diseases
TW083103216A TW308593B (en) 1993-04-16 1994-04-12
NO944809A NO307126B1 (en) 1993-04-16 1994-12-12 Use of biologically active ureido derivatives for the manufacture of a medicament for use in the treatment of lentivirus-induced disease
KR1019940704567A KR950701812A (en) 1993-04-16 1994-12-15 Biologically active ureido dervatives useful in the treatment of lentivirus-induced sisease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939307948A GB9307948D0 (en) 1993-04-16 1993-04-16 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease

Publications (1)

Publication Number Publication Date
GB9307948D0 true GB9307948D0 (en) 1993-06-02

Family

ID=10733998

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939307948A Pending GB9307948D0 (en) 1993-04-16 1993-04-16 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease

Country Status (15)

Country Link
EP (1) EP0646004A1 (en)
JP (1) JPH07508044A (en)
KR (1) KR950701812A (en)
AU (1) AU670194B2 (en)
CA (1) CA2137148A1 (en)
CZ (1) CZ282988B6 (en)
GB (1) GB9307948D0 (en)
HU (1) HU216834B (en)
IL (1) IL109235A (en)
NO (1) NO307126B1 (en)
PL (1) PL306798A1 (en)
RU (1) RU2142798C1 (en)
TW (1) TW308593B (en)
UA (1) UA42693C2 (en)
WO (1) WO1994023718A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504065D0 (en) * 1995-03-01 1995-04-19 Pharmacia Spa Poly-pyrrolecarboxamidonaphthalenic acid derivatives
GB9602721D0 (en) * 1996-02-09 1996-04-10 Pharmacia Spa Biologically active ureido derivatives useful in the treatment of multiple sclerosis
GB2310207A (en) * 1996-02-15 1997-08-20 Pharmacia Spa Antiviral ureido derivatives of substituted heterocyclic compounds
GB9713733D0 (en) * 1997-06-27 1997-09-03 Pharmacia & Upjohn Spa Poly-branched polycarboxamido compounds
EP3381897A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9000644D0 (en) * 1990-01-11 1990-03-14 Erba Carlo Spa New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
AU1224392A (en) * 1991-02-06 1992-09-07 Synphar Laboratories, Inc. Oligopeptide antiretroviral agents

Also Published As

Publication number Publication date
RU94046312A (en) 1996-10-20
CZ10795A3 (en) 1995-09-13
CA2137148A1 (en) 1994-10-27
HUT71838A (en) 1996-02-28
IL109235A0 (en) 1994-07-31
NO944809L (en) 1994-12-12
HU9500120D0 (en) 1995-03-28
CZ282988B6 (en) 1997-12-17
EP0646004A1 (en) 1995-04-05
TW308593B (en) 1997-06-21
PL306798A1 (en) 1995-04-18
HU216834B (en) 1999-09-28
AU6537194A (en) 1994-11-08
KR950701812A (en) 1995-05-17
RU2142798C1 (en) 1999-12-20
UA42693C2 (en) 2001-11-15
WO1994023718A1 (en) 1994-10-27
IL109235A (en) 1998-09-24
AU670194B2 (en) 1996-07-04
JPH07508044A (en) 1995-09-07
NO944809D0 (en) 1994-12-12
NO307126B1 (en) 2000-02-14

Similar Documents

Publication Publication Date Title
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
HUT74608A (en) Biologically active silicon-compounds and their pharmaceutical and cosmetical use
PL305981A1 (en) Biologically active ureido derivatives useful as ananti-metastatic agents
ZA941199B (en) Physiologically active compound HS-1 and process for the preparation of the same
HU9500120D0 (en) Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
IL107768A0 (en) Treatment of agricultural produce
GR3033332T3 (en) Biologically active ureido derivatives useful in the treatment of multiple sclerosis
EP0840605A4 (en) Compounds useful in the treatment of neurofibromatosis
GB9316004D0 (en) Improvements in or relating to the treatment of sickle cell disease
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
GB9218709D0 (en) Biologically active health formulation
GB9310608D0 (en) Biologically active dermatological treatment
GB9218772D0 (en) Biologically active dermatological treatment
GB9208553D0 (en) Biologically active ureido derivative
GB9308573D0 (en) Biologically and therapeutically active agents
GB9309565D0 (en) Biologically and therapeutically active agents
GB9119202D0 (en) Biologically and therapeutically active agents
GB9207273D0 (en) Biologically and therapeutically active agents
GB9215546D0 (en) Biologically and therapeutically active agents
ZA969968B (en) Use of 2-iminobenzothiazolines in the treatment of parkinson's disease and parkinsonian syndromes
SI0814813T1 (en) Use of penciclovir for the treatment of human herpes-virus-8
GB9218907D0 (en) Biologically active molecules
GB9509894D0 (en) Biologically and therapeutically active agents
GB9511773D0 (en) Biologically and therapeutically active agents